Senior insider sale
TARSUS PHARMACEUTICALS, INC. — senior position signals high conviction
$770.8K
9.99K shares
What this filing means
LIN ELIZABETH YEU plans to sell 9.99K shares of TARSUS PHARMACEUTICALS, INC. valued at approximately $770.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/2/2026ACC: 0001959173-26-006652
Director
Since Dec 2021
9.99K
Shares to sell
$770.8K
Approx. market value
5.39K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Open Market Purchase
Cash
8/15/2023
2.38KOpen Market Purchase
Cash
9/14/2022
3.01KTotal acquired5.39K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/15/2023 | Open Market Purchase Cash | 2.38K | — |
9/14/2022 | Open Market Purchase Cash | 3.01K | — |
| Total | 5.39K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
4.60K
Market value
$339.8K
9/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
5.39K
Market value
$431.0K
9/2/2026
Total
Units
9.99K
Value
$770.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/1/2026 | 4.60K | $339.8K | — | Completed |
| Planned — Approximate Date | ||||
9/2/2026 | 5.39K | $431.0K | NASDAQ | Planned |
| Total | 9.99K | $770.8K | ||